Driven by a passion to alleviate the sufferings of many cancer patients and their families, scientists have made significant steps towards finding the cure for some types of cancer. While finding the cure has been elusive, scientists such as Mikhail Blagosklonny has made significant success towards better understanding cancer and finding a cure. His revolutionary ideas and findings have played a key role in bridging the knowledge gap that exists between cancer and aging process. As an oncologist, he was made significant contributions towards the fight against; one of the leading causes of mortalities in the world.
Education and Career Profile
Mikhail Blagosklonny specializes in experimental medicine with revolutionary potential. He also specializes in internal medicine for both clinical trials and clinical use. He graduated from First Pavlov State Medical University of St. Petersburg with a Doctor of Medicine degree. He also received his Ph.D. in Medicine from the historical and prestigious university. Currently, he is serving as the oncology professor at Roswell Park Cancer Institute. Before taking over at Roswell in 2009, he also worked as an associate professor at New York Medical College from 2002. He also worked as a research scientist for Ordway Research Institute where he specialized in aging and cancer research. In addition to his work as a professor, Mikhail Blagosklonny also doubles up as editor-in-chief for Oncortarget: an open source, weekly and peer-reviewed medicine journal specializing in research on various fields including cancer.
He also holds the same position for the biweekly, peer-reviewed journal Cell Cycle and the monthly journal, Aging. This is in addition to the hundreds of widely-cited articles and book chapters he has authored. His articles have primarily focused on cell aging and cell and molecular biology.
Oncology and Aging Research
Mikhail Blagosklonny is committed to oncology and aging research. Over the years, he has specialized in cell aging and cellular and molecular biology. In one of his landmark researches, he proposed that the signaling by target of rapamycin (TOR) has the capability of delaying cell apoptosis and autophagy. This allows the cells to produce more proteins and therefore extend their lifespan and consequently, delay aging process and cancer treatment. Deeper understanding of TOR signaling can be crucial in developing anti-aging and cancer drugs. Visit classroomvoices.org to read more about Mikhail.